Kinomica is a UK-based precision medicine company specialising in phosphoproteomic diagnostics to enhance cancer treatment decisions. Its proprietary KScan® platform analyses protein phosphorylation to identify activated signalling pathways, aiding clinicians in selecting optimal therapies for individual patients.
- Investment status Current
- Invested 2024
- Category Health & Life Sciences